Wegovy is an approved weight loss medication for overweight and obese adults with various comorbidities. Novo Nordisk produces the drug and has been on the market since 2011.
Suppose your body mass index (BMI) is over 27, and you suffer from high blood pressure, type 2 diabetes, high cholesterol, or other diseases afflicting adults above a healthy weight. In that case, Wegovy could be right for you.
Wegovy is a GLP-1 class drug that reduces feelings of hunger and increases feelings of satiety among individuals above a normal BMI.
Wegovy may be effective in weight loss, and users can experience weight loss when the medication is combined with lifestyle changes.
In studies of Wegovy users, those who adopted reduced-calorie diets and increased physical activity lost 15% of their starting body weight.